Vigene Biosciences is a leading biotechnology company providing viral vector-based gene delivery services and products for research and clinical applications.
​
Dr Jeffery Hung leads a diverse and international team of molecular biologists, virologists, engineers, quality professionals and supporting staff on a mission to make gene therapy affordable.
​
Vigene has continued to serve both research and clinical communities and has been recognised with national awards.
​
Phase 1 of our project, creating the vector that is the mechanism that will deliver the new therapy to the cells of the body, was undertaken by Vigene, so you will appreciate what a key partner they are for the success of this research.